ALABUKUN

This brand name is authorized in Nigeria.

Active ingredients

The drug ALABUKUN contains a combination of these active pharmaceutical ingredients (APIs):

1	Acetylsalicylic acid UNII R16CO5Y76E - ASPIRIN
	Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs.
	Read more about Acetylsalicylic acid
2	Caffeine UNII 3G6A5W338E - CAFFEINE
	Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant.
	Read more about Caffeine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-0489	Powder	ALABUKUN POWDER PWD 760 mg; 60 mg 10 X 10	32 RNW-PP-112072 ALABUKUN POWDER ALABUKUN ACETYLSALICYLIC ACID 760MG, CAFFEINE 60MG 04-0489 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Nigerian Products 1010 Over The Counter (OTC) 12/19/2019 COPAC NIG LTD, APAPA-OSHODI EXPRESS WAY ISOLO LAGOS 17358612 eosofunke@gmail.com COPAC Nigeria Limited, Plot K6, Apapa-Oshodi Expressway, Isolo, Lagos, Nigeria, Nigeria	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02BA51	Acetylsalicylic acid, combinations excl. psycholeptics	N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BA Salicylic acid and derivatives
Discover more medicines within N02BA51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-0489